Description
The Veterinary Team at Hagyard Equine Medical Institute in Lexington, Kentucky has discovered the potency of a polysaccharide formula targeting Equine Gastric Ulcer Syndrome (EGUS). Previous pre-clinical successes with other species drove their investigation. As you know, the prevalence of gastric ulcers in horses is high across all disciplines and effects overall condition, performance, and behaviour. The Hagyards Veterinary team sought an alternative to traditional treatment options for EGUS that would be effective and safe for continuous use without altering the GI Ph. Join us to hear how their investigations and continued field-use have resulted in the creation of Relyne GI.
